About Us

No one can solve the tough challenges of pediatric health care alone. We need to build creative, durable relationships that will spawn new discoveries, improve care and accelerate the benefits for children. Boston Children’s embraces partnerships to fuel greater and faster innovation, ensuring that life-changing visions become reality and create a healthier future for our children. We approach every challenge with the question of how and with whom can we partner to make the work bigger, better, more productive. Join us.
– Sandra L. Fenwick, President and CEO

Boston Children’s Hospital invests heavily in research because science saves lives. We are focused on accelerating new treatments for devastating diseases — our discoveries translate from the laboratory bench to the patient’s bedside, where they have been improving the health of children and adults since 1869. 

Today, our research enterprise is the world's largest and most highly-funded at a pediatric hospital, attracting $333 million in funding support in fiscal year 2016 alone. More than 2,600 basic, clinical and translational scientists work in our dedicated research facilities, which total nearly one million square feet of space. 

Members of our research community include eight members of the National Academy of Sciences, 14 members of the National Academy of Medicine, 12 Howard Hughes Medical Institute Investigators and eight Lasker Award recipients. In total, our research community publishes more peer-reviewed research in top scientific journals than the next 20 children’s hospitals combined.


Since its founding, Boston Children’s has embodied a culture of innovation. Our commitment to partnerships — across disciplines, with nursing, with Harvard Medical School and other academic medical centers — makes us truly unique.

We’ve created programs to take partnerships to the next level, focusing on collaborations that leverage and optimize the unique assets of each partner to yield an arrangement that is greater than the sum of its parts. Our Technology and Innovation Development Office (TIDO) and Innovation & Digital Health Accelerator (IDHA)—provide a robust foundation for vibrant partnerships with industry and across the innovation community.

Our commitment to partnerships has garnered impressive results:

  • Boston Children’s is the first pediatric organization to partner with Blue Cross Blue Shield of Massachusetts' Alternative Quality Contract (AQC). The AQC offers providers a baseline budget to cover the continuum of care, and has delivered a small yet significant positive effect on preventive and acute-care quality when tied to pay-for-performance models.
  • A partnership between Boston Children’s and Shire, focused on rare diseases, builds on the organizations’ complementary strengths: Boston Children’s research capabilities and Shire’s development and commercialization infrastructure. The goal of the three-year partnership is to develop novel therapies to treat a number of rare pediatric diseases with high unmet medical need.
  • A partnership between Boston Children’s and IBM delivers OPENPediatrics, an interactive digital learning platform, free to clinicians across the globe, exponentially increasing access to essential educational materials and improving the practice of critical care medicine.
  • Boston Children's spun out its molecular medicine laboratory into Claritas Genomics, an independent, first of its kind, pediatric clinical genomics diagnostics company. Cincinnati Children’s Hospital has joined Claritas, beginning the formation of a genomic network of pediatric hospitals.